These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 13232215)

  • 21. [Pharmacological and clinical aspects of combined diuretic-sedative therapy of heart diseases].
    MECIANI L; BRINA A
    Minerva Cardioangiol; 1957 Oct; 5(10):417-23. PubMed ID: 13503737
    [No Abstract]   [Full Text] [Related]  

  • 22. Diethylammonium paraaminobenzoate in psychiatric practice.
    LANDRIANI F
    Gazz Med Ital; 1952 Oct; 111(10):269-72. PubMed ID: 13021413
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical experiences with the oral administration of strophanthin G].
    MANCINI D; CAPITAINE CACERES R
    Dia Med; 1960 Mar; 32():358-60. PubMed ID: 14420506
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical experiences concerning the effect of strophanthin.
    FROST J; WARBURG E
    Acta Med Scand; 1948; 131(Suppl 206):132-44. PubMed ID: 18881130
    [No Abstract]   [Full Text] [Related]  

  • 25. [Primary results in the combination of d-fructopyranosidase with strophanthin K in therapy of heart disease].
    PUECH A; COMBIER C; CARLI N; PUECH P
    Montp Med; 1953 Aug; 44(2):89-92. PubMed ID: 13119719
    [No Abstract]   [Full Text] [Related]  

  • 26. [Polyclinical treatment of heart disease with cynosid liquidum].
    STORCH H
    Ther Ggw; 1952 Mar; 91(3):102-4. PubMed ID: 12984383
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of digitalis on strophanthin refractive heart diseases].
    GOTTSEGEN G
    Orv Hetil; 1953 May; 94(19):518-21. PubMed ID: 13088014
    [No Abstract]   [Full Text] [Related]  

  • 28. [Stabilizing effect of paraaminobenzoate of diethylammonium on the autonomic nervous system].
    FIORENTINO M
    Gazz Med Ital; 1954 Aug; 113(8):209-42. PubMed ID: 13210619
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of diethylammonium p-aminobenzoate in some medical syndromes].
    GIANDOSO L; GROPPI C
    Rass Medica; 1951 Aug; 28(8):143-6. PubMed ID: 14883411
    [No Abstract]   [Full Text] [Related]  

  • 30. [Application of strophanthin in cardiotonic therapy].
    STANULOVIC D
    Med Pregl; 1952; (13-14-15):333. PubMed ID: 12982371
    [No Abstract]   [Full Text] [Related]  

  • 31. [Intravenous strophanthin therapy in heart diseases and its importance in general practice].
    ASCHENBRENNER R
    Dtsch Med Wochenschr; 1956 Dec; 81(50):1988-91. PubMed ID: 13397271
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacological study of p-aminobenzoate of diethylammonium].
    MAINARDI L; SEMENZA F
    Boll Soc Ital Biol Sper; 1951 Mar; 27(3 bis):275-6. PubMed ID: 14858631
    [No Abstract]   [Full Text] [Related]  

  • 33. [Critical remarks on intravenous strophanthin therapy].
    MULLER R; SCHILD W
    Arztl Wochensch; 1956 Nov; 11(46):1010-3. PubMed ID: 13394460
    [No Abstract]   [Full Text] [Related]  

  • 34. [Absorption, elimination and distribution in organs of p-aminobenzoate of diethylammonium].
    MAINARDI L
    Boll Soc Ital Biol Sper; 1951 Mar; 27(3 bis):350-2. PubMed ID: 14858664
    [No Abstract]   [Full Text] [Related]  

  • 35. [Action of p-aminobenzoate of diethylammonium on the neuromuscular system].
    MAINARDI L; SEMENZA F
    Boll Soc Ital Biol Sper; 1952 Apr; 28(4):729-31. PubMed ID: 13018470
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical use of strophanthin in the form of strophil].
    HAGGENMILLER W; GESCHKE HJ
    Munch Med Wochenschr; 1959 May; 101(19):848-51. PubMed ID: 13666753
    [No Abstract]   [Full Text] [Related]  

  • 37. [Miroton as adjuvant for the performance of ambulant strophanthin therapy after dismissal from the hospital & restored compensation].
    ANGSTER H
    Medizinische; 1958 Jan; 2(2):90-2. PubMed ID: 13516220
    [No Abstract]   [Full Text] [Related]  

  • 38. [Influence of age on the effect of strophanthin in man].
    MICHEL D; HARTLEB O; MARXHAUSEN E
    Z Klin Med; 1958; 155(3):288-309. PubMed ID: 13604588
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of conduction failures with smallest strophantin doses].
    RENNEBERG W
    Med Monatsschr; 1953 Apr; 7(4):237-9. PubMed ID: 13086509
    [No Abstract]   [Full Text] [Related]  

  • 40. [Problem of an increase of strophanthin effect by cocarboxylase].
    MICHEL D; HARTLEB O
    Z Kreislaufforsch; 1959 Jun; 48(11-12):557-70. PubMed ID: 13676632
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.